Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice - Wikidata - wikimedia - TriplyDB

Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice

Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice

http://www.wikidata.org/entity/Q33891214

about

ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses Txk, a member of the non-receptor tyrosine kinase of the Tec family, forms a complex with poly(ADP-ribose) polymerase 1 and elongation factor 1alpha and regulates interferon-gamma gene transcription in Th1 cells The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism Modulation of nucleosome-binding activity of FACT by poly(ADP-ribosyl)ation The HIV-1 Vpr and glucocorticoid receptor complex is a gain-of-function interaction that prevents the nuclear localization of PARP-1 Nitric oxide and peroxynitrite in health and disease Nuclear translocation of p65 NF-kappaB is sufficient for VCAM-1, but not ICAM-1, expression in TNF-stimulated smooth muscle cells: Differential requirement for PARP-1 expression and interaction TRPM2 channel opening in response to oxidative stress is dependent on activation of poly(ADP-ribose) polymerase Regulation of poly(ADP-ribose) polymerase 1 activity by the phosphorylation state of the nuclear NAD biosynthetic enzyme NMN adenylyl transferase 1 Bench-to-bedside review: Cytopathic hypoxia Enhancing tumor-targeting monoclonal antibodies therapy by PARP inhibitors The Role of Poly(ADP-ribose) Polymerase-1 in Rheumatoid Arthritis Pleiotropic cellular functions of PARP1 in longevity and aging: genome maintenance meets inflammation Targeting TRPM2 in ROS-Coupled Diseases Understanding specific functions of PARP-2: new lessons for cancer therapy The enzymatic and DNA binding activity of PARP-1 are not required for NF-kappa B coactivator function Chemokine-cytokine cross-talk. The ELR+ CXC chemokine LIX (CXCL5) amplifies a proinflammatory cytokine response via a phosphatidylinositol 3-kinase-NF-kappa B pathway Centromere proteins Cenpa, Cenpb, and Bub3 interact with poly(ADP-ribose) polymerase-1 protein and are poly(ADP-ribosyl)ated Inhibition of poly (ADP-ribose) synthetase by gene disruption or inhibition with 5-iodo-6-amino-1,2-benzopyrone protects mice from multiple-low-dose-streptozotocin-induced diabetes Depletion of the 110-kilodalton isoform of poly(ADP-ribose) glycohydrolase increases sensitivity to genotoxic and endotoxic stress in mice PARP-1 Inhibition Is Neuroprotective in the R6/2 Mouse Model of Huntington's Disease Regulation of myofibroblast differentiation by poly(ADP-ribose) polymerase 1 Enhanced NF-κB activity impairs vascular function through PARP-1-, SP-1-, and COX-2-dependent mechanisms in type 2 diabetes.Microglial involvement in neuroplastic changes following focal brain ischemia in rats.Identification of poly(ADP-ribose)polymerase-1 and Ku70/Ku80 as transcriptional regulators of S100A9 gene expression Poly(ADP-ribose) polymerase-1 regulates vimentin expression in lung cancer cells.Therapeutic effect of a poly(ADP-ribose) polymerase-1 inhibitor on experimental arthritis by downregulating inflammation and Th1 response.Global analysis of transcriptional regulation by poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in MCF-7 human breast cancer cells Poly(ADP-ribose) polymerase-1 and its cleavage products differentially modulate cellular protection through NF-kappaB-dependent signaling Elevated DNA Oxidation and DNA Repair Enzyme Expression in Brain White Matter in Major Depressive Disorder.Upregulation of Salmonella-induced IL-6 production in Caco-2 cells by PJ-34, PARP-1 inhibitor: involvement of PI3K, p38 MAPK, ERK, JNK, and NF-kappaB PARP-1 hyperactivation and reciprocal elevations in intracellular Ca2+ during ROS-induced nonapoptotic cell death Postischemic poly (ADP-ribose) polymerase (PARP) inhibition reduces ischemia reperfusion injury in a hind-limb ischemia model.Regulation of alpha-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene.Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia.Poly(ADP-ribose) polymerase-1 is a determining factor in Crm1-mediated nuclear export and retention of p65 NF-kappa B upon TLR4 stimulation.Role of nicotinamide in DNA damage, mutagenesis, and DNA repair.New facets in the regulation of gene expression by ADP-ribosylation and poly(ADP-ribose) polymerases.Lessons from the NZM2410 model and related strains.Loss of poly(ADP-ribose) polymerase-1 causes increased tumour latency in p53-deficient mice

P2860

Q24307928-F39D6421-092B-4B88-8457-BE98B4D3A537 Q24337273-5F331C7D-B0CC-4E62-8311-8CE3B8BBAEA5 Q24337667-0A20A3DC-EA37-4BE3-98F8-83F6C4EBD7F5 Q24546240-C5FA3960-441F-47FB-B354-F65FF7CFEBCE Q24629787-A64D177D-4030-4F5A-9685-12F39A504819 Q24645400-41E117C0-F48E-4BBE-A172-170A06F6DBA8 Q24647748-5038010F-F4EA-4D39-A906-36E23FC2E3B1 Q24671634-FBC9F528-69D2-4F78-9D0A-7BEA0E746E70 Q24681295-1236FF57-2883-417A-AD5F-5CDF25A2B63C Q24807180-3B31F362-6B45-48E6-8571-1E42E86823FA Q26768267-20249EC7-1C35-4368-83F2-5FF4BD4BAAFF Q26785513-AB86DD3C-CAA6-4C44-91E2-705B2B032677 Q26858894-CB183C6D-DC9A-4363-9321-D4404C7EC029 Q28067161-192F71CB-1F38-46DE-8BA6-0D86158B3988 Q28067486-B66A6A2E-58A1-4070-A4C3-5572699CB4DE Q28190711-DE2DD148-B892-4B33-8186-0F3ED6F4CF5F Q28216747-D6813C3B-E864-4C68-8B5C-05D63A1DC9F9 Q28217564-8CA24395-CA69-4300-9F17-EAB99B614E21 Q28343931-4BD0C6E3-DD96-4F25-A2D4-1FFC326D6B2B Q28508144-AB86B24E-1F9B-489C-8ADE-E8B719A97DD2 Q28547107-F6A4C830-11C1-4F82-A365-E1D0013AE2FE Q28564646-2588BA74-ADAE-4E07-B92A-C9821A222B16 Q30540016-24258143-9C80-4283-B5AA-9B7B956B8532 Q30940972-4ED7F6EF-93ED-4536-9BF7-211E8EAEF898 Q33267541-E2B0E2C3-1F71-4FC7-A94B-625F5FC5580E Q33295158-69E6FCBF-B222-4F4D-B40F-33309796437A Q33304428-22FE6A9B-8933-4938-BF13-6F77D630300F Q33553364-0C566862-8F32-4E73-A2E8-A3B8864E4225 Q33578933-A4A5550D-9C94-47C8-A33E-69F5EE16FE1A Q33623455-36AEC50E-39CB-4381-B66A-98075D9AAE1F Q33686393-1A352AB2-A0AA-48B2-8EBA-809566D49BD2 Q33845289-FB8BE00C-654D-4940-A363-21FEB1E690A7 Q33915402-AE37BD56-F94F-4CC0-B7EB-7DCC4FF78819 Q33938665-931A5EE8-7A37-4B10-9AD9-FBB3ED9B78B2 Q34017468-A866619F-C863-4056-A54E-5616A64CC4E9 Q34023297-F20D996A-0C65-48C6-B5DF-B81759641259 Q34042309-B4E451D6-78D1-444F-AA13-D48A2EB40AC2 Q34042969-5AB87B59-29EF-4570-941B-2873DB5A84B8 Q34051998-583AE0C6-4857-4A0A-95EA-09338B4A6057 Q34080033-5030BC83-5398-4263-B87C-B6ED04187E97

P2860

Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice

http://www.wikidata.org/entity/Q33891214

description

1999 nî lūn-bûn

@nan

1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Resistance to endotoxic shock ...... e) polymerase-1 deficient mice

@ast

Resistance to endotoxic shock ...... e) polymerase-1 deficient mice

@en

type

label

Resistance to endotoxic shock ...... e) polymerase-1 deficient mice

@ast

Resistance to endotoxic shock ...... e) polymerase-1 deficient mice

@en

prefLabel

Resistance to endotoxic shock ...... e) polymerase-1 deficient mice

@ast

Resistance to endotoxic shock ...... e) polymerase-1 deficient mice

@en

P1433

Q33891214-B9D2FA67-7EA8-4DE7-AE96-80B6D2BFC416

P1476

Q33891214-32AF0AD8-0365-4E6B-B61D-7D0E78BA3C92

P2093

Q33891214-0D8FBB17-FEA8-4531-9409-803B7EBEE7B9

Q33891214-0FC812C9-5E5E-4D1E-BA0F-4F91100360E2

Q33891214-2C5775C0-8EB5-4658-A74B-90B02E273157

Q33891214-576F22C7-3625-4609-BB28-429AB17BCF68

Q33891214-607B9A77-B3EC-4F69-8EC0-7E9B8F127E2E

Q33891214-955C5F26-D92B-4149-B1E4-908919B66047

Q33891214-AD1CD75D-0CA1-4E36-8F99-DEBD9ED55842

Q33891214-C7448FCA-4200-4D56-B768-F93B31B6D6C9

Q33891214-F77FACEF-C7B3-4C43-AED9-268F2A3BFC22

P304

Q33891214-E9CE6CF3-EF77-49CF-9969-9A7E521C6B8A

P31

Q33891214-B15FFADB-2567-49C2-A476-2E146D1F4727

P356

Q33891214-DBD70188-110D-43C6-AC95-4BC4E4A4E543

P407

Q33891214-55FF96BA-EC6F-4BDB-BED1-362C1288F6DC

P433

Q33891214-5B7EEC22-28F8-4765-ADDC-3CADB857A4CC

P478

Q33891214-F8D16F12-A473-4632-9992-8D3FA1A32FAF

P577

Q33891214-37559D33-9E61-4A48-BE4B-398A1065C5C1

P5875

Q33891214-40BA67ED-D8C4-49B0-8704-AF3C8E0672E0

P698

Q33891214-5174B7B1-DDC9-48C9-9C8C-C4812C492D72

P921

Q33891214-34683ADC-DECF-4E1D-BEE0-A6B29B1CB499

P932

Q33891214-78583CDC-6B6F-4A6D-8CE2-84C808DA4D27

P356

P1433

The EMBO Journal

P1476

Resistance to endotoxic shock ...... e) polymerase-1 deficient mice

@en

P2093

C Nacci

http://www.w3.org/2001/XMLSchema#string

F J Oliver

http://www.w3.org/2001/XMLSchema#string

G de Murcia

http://www.w3.org/2001/XMLSchema#string

G de la Rubia

http://www.w3.org/2001/XMLSchema#string

J C Stoclet

http://www.w3.org/2001/XMLSchema#string

J Ménissier-de Murcia

http://www.w3.org/2001/XMLSchema#string

P Decker

http://www.w3.org/2001/XMLSchema#string

R Andriantsitohaina

http://www.w3.org/2001/XMLSchema#string

S Muller

http://www.w3.org/2001/XMLSchema#string

P304

4446-4454

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EMBOJ/18.16.4446

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

1999-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12851240

http://www.w3.org/2001/XMLSchema#string

P698

10449410

http://www.w3.org/2001/XMLSchema#string

P921

P932

1171519

http://www.w3.org/2001/XMLSchema#string